FY2024 EPS Estimates for Humana Boosted by Cantor Fitzgerald

Humana Inc. (NYSE:HUM) – Analysts at Cantor Fitzgerald increased their FY2024 EPS estimates for shares of Humana in a report released on Thursday, October 31st. Cantor Fitzgerald analyst S. James now expects that the insurance provider will post earnings of $16.17 per share for the year, up from their prior estimate of $16.04. Cantor Fitzgerald currently has a “Neutral” rating and a $395.00 price objective on the stock. The consensus estimate for Humana’s current full-year earnings is $16.10 per share.

Several other equities analysts have also recently weighed in on HUM. JPMorgan Chase & Co. boosted their price objective on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and cut their price target for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. Bank of America lowered Humana from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $376.00 to $247.00 in a research report on Wednesday, October 2nd. Leerink Partnrs cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, UBS Group decreased their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and an average price target of $312.95.

Humana Price Performance

Shares of HUM opened at $255.55 on Monday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.66. Humana has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The business’s 50-day moving average is $295.11 and its 200-day moving average is $334.03. The company has a market capitalization of $30.77 billion, a price-to-earnings ratio of 22.64, a P/E/G ratio of 2.00 and a beta of 0.52.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion.

Institutional Trading of Humana

Large investors have recently added to or reduced their stakes in the stock. Norden Group LLC grew its stake in Humana by 137.9% during the first quarter. Norden Group LLC now owns 1,130 shares of the insurance provider’s stock valued at $392,000 after acquiring an additional 655 shares in the last quarter. J.W. Cole Advisors Inc. purchased a new position in shares of Humana in the 1st quarter valued at approximately $281,000. Mirae Asset Global Investments Co. Ltd. lifted its position in Humana by 9.2% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 41,412 shares of the insurance provider’s stock valued at $14,358,000 after acquiring an additional 3,501 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its holdings in Humana by 4.8% in the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 2,863 shares of the insurance provider’s stock worth $993,000 after acquiring an additional 132 shares in the last quarter. Finally, Jennison Associates LLC purchased a new stake in shares of Humana during the first quarter valued at approximately $46,885,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.39%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.